MicroVention's New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony

MicroVention's New Manufacturing Plant Facility In Costa Rica Celebrates Grand
                    Opening With Inaugural Plant Ceremony

PR Newswire

TUSTIN, Calif., March 6, 2013

TUSTIN, Calif., March 6, 2013 /PRNewswire/ -- MicroVention, Inc., a wholly
owned subsidiary of Terumo Corporation, announced that its new manufacturing
facility in San Jose, Costa Rica is now open. The Company also held a Grand
Opening Ceremony today to commemorate this exciting new venture for
MicroVention. The new plant represents MicroVention's first manufacturing
facility outside the United States and the first Neurovascular manufacturing
facility in Costa Rica, which is located at the Coyol Free Zone in the
Alajuela region of Costa Rica.

The Plant Opening Ceremony was attended by numerous dignitaries and executives
from the business district including the Vice President of Costa Rica, Luis
Lieberman Ginsburg. Other executives who attended from MicroVention's parent
company included Mr. Yutaro Shintaku, President and Representative Director;
Mr. Shinjiro Sato, Senior Executive Officer, Group President, Cardiac and
Vascular Business Group, both of Terumo Corporation located in Tokyo, Japan
and Mr. Hideo Arase, President and CEO of Terumo Americas Holding. Also in
attendance was the Costa Rican Investment Promotion Agency (CINDE) which has
supported MicroVention in establishing its plant in Costa Rica. "MicroVention
will be the first company specializing in the neurovascular segment, and we
are excited to welcome MicroVention to the Alajuela region," commented
Gabriela Llobet, CINDE´s Director General.

This new facility will support the growth and expansion of products offered
under the MicroVention and Terumo brand and the Company has hired
approximately 150 Associates with plans to expand in the coming months/years.
The new plant is located just outside of San Jose, the nation's capital (the
size of the new facility is 7,500 M^2/80,000 sq. ft. and will encompass a
2,300 M^2 clean room/25,000 sq. ft.).

"We are very excited about the initiation of our first manufacturing facility
in Costa Rica and commemorating the opening with many of our new partners
celebrating with us. Our intent was to create a world-class facility
extension of our corporate manufacturing plant in Tustin, CA, USA, and we have
achieved that goal today," said Richard Cappetta, President and Chief
Executive Officer of MicroVention, Inc. In attendance besides the Company's
President and CEO were several other members of the MicroVention Executive
Staff including William R. Hughes, Chief Operating Officer and Treasurer;
Cherie Henket, Vice President, Human Resources; Matt Fitz, Sr. Vice President,
Research and Development and Operations; Mr. Uichi Okina, Vice President,
Strategic Planning, Business Development; and Charlie Noel, Vice President,

Approximately 12,000 people currently work in the Life Sciences Sector in
Costa Rica with 41 medical device companies producing orthopedic,
cardiovascular, women's health devices, and medical supplies. MicroVention
will be the first company specializing in the neurovascular segment in Costa
Rica. MicroVention has been recruiting its first employees, specifically in
the areas of Engineering, Quality, Production and Administration. Persons
interested in applying can visit the "Careers – Costa Rica" page of the
MicroVention website at www.microvention.com.

About Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device
manufacturers with $5 billion in sales and operations in more than 160
nations. Founded in 1921, the company develops, manufactures and distributes
world-class medical devices including products for use in cardiothoracic
surgery, interventional procedures and transfusion medicine; the company also
manufactures a broad array of syringe and hypodermic needle products for
hospital and physician office use. Terumo contributes to society by providing
valued products and services to the health care market and by responding to
the needs of health care providers and the people they serve. Terumo
Corporation's shares are listed on the first section of the Tokyo Stock
Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a
component of the Nikkei 225, Japan's leading stock index.

About MicroVention, Inc.

MicroVention, Inc. is a U.S. subsidiary of Terumo Corporation with its
corporate headquarters in Tustin, California, and manufacturing and
administrative facilities in Santa Ana and Aliso Viejo, California, and San
Jose, Costa Rica. MicroVention is a developer, manufacturer and marketer of
innovative neuroendovascular technologies for the treatment of vascular
diseases in small vessels. MicroVention products are sold throughout the
world in more than 60 countries. For more information, visit

Media Contact:

Cathy Demyanovich
Sr. Director, Corporate Communications
MicroVention. Inc.

SOURCE MicroVention, Inc.

Website: http://www.microvention.com
Press spacebar to pause and continue. Press esc to stop.